Trial
NCT04294459
Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Sanofi
Collaborators
—
Condition
Immune System Disorder
Intervention
Isatuximab SAR650984
Why stopped
Terminated due to non-safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-17